share_log

Merck & Co | 4: Statement of changes in beneficial ownership of securities-Officer Davis Robert M

SEC announcement ·  Jan 25 05:12
Summary by Futu AI
Merck & Co, Inc. (MRK) reported that its Chairman, CEO & President, Davis Robert M, completed a purchase of company stock on January 22, 2024. The transaction involved the acquisition of 76,510 shares of Merck's common stock at a price of $119.43 per share. Following this transaction, Davis now directly holds a total of 348,327 shares in the company. The total value of the shares acquired is approximately $9.14 million. This transaction reflects a direct investment by the executive in the company and is indicative of his confidence in Merck's future performance.
Merck & Co, Inc. (MRK) reported that its Chairman, CEO & President, Davis Robert M, completed a purchase of company stock on January 22, 2024. The transaction involved the acquisition of 76,510 shares of Merck's common stock at a price of $119.43 per share. Following this transaction, Davis now directly holds a total of 348,327 shares in the company. The total value of the shares acquired is approximately $9.14 million. This transaction reflects a direct investment by the executive in the company and is indicative of his confidence in Merck's future performance.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.